Geode Capital Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-185,982
| Closed | -$1.18M | – | 4879 |
|
|
2022
Q4 | $1.18M | Hold |
185,982
| – | – | ﹤0.01% | 3278 |
|
|
2022
Q3 | $952K | Buy |
185,982
+7,043
| +4% | +$44.2K | ﹤0.01% | 3416 |
|
|
2022
Q2 | $1.12M | Buy |
178,939
+33,508
| +23% | +$113K | ﹤0.01% | 3375 |
|
|
2022
Q1 | $516K | Hold |
145,431
| – | – | ﹤0.01% | 3919 |
|
|
2021
Q4 | $730K | Hold |
145,431
| – | – | ﹤0.01% | 3859 |
|
|
2021
Q3 | $1.06M | Buy |
145,431
+15,152
| +12% | +$104K | ﹤0.01% | 3641 |
|
|
2021
Q2 | $1.12M | Buy |
130,279
+75,279
| +137% | +$642K | ﹤0.01% | 3533 |
|
|
2021
Q1 | $595K | Buy |
55,000
+35,668
| +185% | +$346K | ﹤0.01% | 3747 |
|
|
2020
Q4 | $190K | Sell |
19,332
-2
| -0% | -$13 | ﹤0.01% | 3904 |
|
|
2020
Q3 | $103K | Hold |
19,334
| – | – | ﹤0.01% | 3901 |
|
|
2020
Q2 | $113K | Hold |
19,334
| – | – | ﹤0.01% | 3816 |
|
|
2020
Q1 | $71K | Hold |
19,334
| – | – | ﹤0.01% | 3854 |
|
|
2019
Q4 | $122K | Hold |
19,334
| – | – | ﹤0.01% | 3936 |
|
|
2019
Q3 | $270K | Sell |
19,334
-87
| -0.4% | -$1.43K | ﹤0.01% | 3680 |
|
|
2019
Q2 | $286K | Sell |
19,421
-11,277
| -37% | -$302K | ﹤0.01% | 3672 |
|
|
2019
Q1 | $1.29M | Buy |
30,698
+1,483
| +5% | +$62.5K | ﹤0.01% | 3058 |
|
|
2018
Q4 | $1.21M | Buy |
29,215
+2,349
| +9% | +$106K | ﹤0.01% | 3026 |
|
|
2018
Q3 | $1.29M | Buy |
26,866
+7,186
| +37% | +$360K | ﹤0.01% | 3105 |
|
|
2018
Q2 | $932K | Buy |
19,680
+7,164
| +57% | +$398K | ﹤0.01% | 3213 |
|
|
2018
Q1 | $769K | Hold |
12,516
| – | – | ﹤0.01% | 3239 |
|
|
2017
Q4 | $673K | Hold |
12,516
| – | – | ﹤0.01% | 3247 |
|
|
2017
Q3 | $843K | Buy |
12,516
+7,472
| +148% | +$428K | ﹤0.01% | 3186 |
|
|
2017
Q2 | $273K | Buy |
+5,044
| New | +$234K | ﹤0.01% | 3573 |
|
Geode Capital Management's FSTX Position: Q1 2023 in Review
Geode Capital Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 185,982 shares — an estimated $1.18M sold.
Geode Capital Management first reported a position in FSTX in Q2 2017 and held it in 23 quarters. The position peaked at $1.29M in Q3 2018. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Geode Capital Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Geode Capital Management sold 185,982 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.18M.
- Geode Capital Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 23 quarters.
- Geode Capital Management's F-star Therapeutics, Inc. Common Stock position peaked at $1.29M in Q3 2018.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.